ITI Pharma and Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Rating:
Key Metrics
Aum
₹251.87 Cr
Expense Ratio
2.66%
Exit Load
0.50%
Min. Investment
₹5,000.00
Min. SIP
₹500.00
Launch Date
11 Nov 2021
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +2.44% | -- |
| 3 Months | +7.76% | -- |
| 6 Months | +19.76% | -- |
| 1 Year | +10.34% | +10.34% |
| 2 Years | -- | +7.25% |
| 3 Years | +64.72% | +18.1% |
| 5 Years | -- | 0% |
| Since Launch | +80.22% | +13.19% |
Holdings as on 17 Aug 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 34.87 | 13.26 |
| Divi's Laboratories | 20.94 | 7.97 |
| Apollo Hospitals Enterprise | 15.90 | 6.05 |
| Max Healthcare Institute | 13.27 | 5.05 |
| Torrent Pharmaceuticals | 12.73 | 4.84 |
| Cipla | 11.65 | 4.43 |
| Dr Reddy's Laboratories | 11.59 | 4.41 |
| Laurus Labs | 11.07 | 4.21 |
| Aurobindo Pharma | 10.10 | 3.84 |
| Mankind Pharma | 8.92 | 3.39 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.72
Sharpe Ratio
16.40%
Std. Deviation
--
Tracking Error
--
Alpha
--
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| LIC MF Healthcare Fund Regular Growth | +14.19% | +21.04% | +11.79% |
| Quant Healthcare Fund Regular Growth | +18.11% | +19.51% | -- |
| ITI Pharma and Healthcare Fund Regular Growth | +10.34% | +18.1% | -- |
| Kotak Healthcare Fund Regular Growth | +22.53% | -- | -- |
| PGIM India Healthcare Fund Regular Growth | +21.89% | -- | -- |
Results are calculated on CAGR basis
About Fund
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
The ITI Pharma and Healthcare Fund Regular Growth has an AUM of 251.87 crores & has delivered CAGR of 0.00 in the last 5 years. The fund has an exit load of 0.50% and an expense ratio of 2.66%. The minimum investment in ITI Pharma and Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Apollo Hospitals Enterprise, Max Healthcare Institute.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs, Medical Equipment & Supplies.
Some of the similar funds are LIC MF Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, ITI Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, PGIM India Healthcare Fund Regular Growth. ITI Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.72 & a standard deviation of 16.40%.
FAQs
According to the morning star rating ITI Pharma and Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
ITI Pharma and Healthcare Fund Regular Growth is managed by Nilay Dalal,Animesh Singh.
The expense ratio of ITI Pharma and Healthcare Fund Regular Growth is 2.66%.
The 5 year annualized return on ITI Pharma and Healthcare Fund Regular Growth is 0.00% & it has generated 10.34% in the last 1 year.
The minimum investment in ITI Pharma and Healthcare Fund Regular Growth is 5000 Rs.
ITI Pharma and Healthcare Fund Regular Growth has an AUM of 251.87 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.